Via, a Hyaluronic Acid (HLA) Based Vaginal Moisturizer Study

Summary

This study aims to evaluate whether the administration of vaginal estrogen along with Via, a hyaluronic acid-based vaginal moisturizer, offers superior relief from symptoms of genitourinary syndrome of menopause (GSM) in the urogynecologic patient population, compared to administration of vaginal estrogen alone.

Timeline

Start

2025-07-01

Primary completion

2026-05-01

Completion

2026-05-01

Outcome

Outcome not reported

Stopped: “The study was placed on hold by the Sponsor for \~1 year. Given the prolonged hold and absence of participant activity, the study was closed.”

Drugs

Indications

No indication recorded.